CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
U.S. Primary Care Physicians’ Viewpoints on HPV Vaccination for Adults 27–45 Years
-
2021
-
-
Source: J Am Board Fam Med. 34(1):162-170
[PDF-509.73 KB]
Details:
-
Alternative Title:J Am Board Fam Med
-
Personal Author:
-
Description:Introduction:
In June 2019, the Advisory Committee on Immunization Practices (ACIP) recommended shared clinical decision-making (SCDM) regarding human papillomavirus (HPV) vaccination for adults 27–45 years. Our objectives were to assess among primary care physicians: 1) recent practice regarding HPV vaccination for adults 27–45 years, 2) knowledge of HPV and the new SCDM recommendation, and 3) attitudes toward and anticipated effect of the new SCDM recommendation.
Methods:
In October to December 2019, we administered an Internet and mail survey to national networks of 494 general internist (GIM) and 474 family physician (FP) members of the American College of Physicians and American Academy of Family Physicians, respectively.
Results:
Response rate was 64% (617/968, GIM 57%, FP 71%). 58% were aware of the new ACIP recommendation; 42% had recommended HPV vaccination to adults 27–45 years, but most had administered HPV vaccine to very few of these patients (73% to 0 and 22% to 1–3). 55% and 63% were unaware that HPV vaccination does not prevent progression of existing HPV-related cancers or infections, respectively. 57% were not sure what to emphasize when having a SCDM conversation about HPV vaccination. A majority reported they will be more likely recommend HPV vaccination to adults in the 27–45 years age range as a result of the new recommendation.
Conclusions:
Physicians are interested in recommending HPV vaccination for adults age 27–45 years despite ACIP not routinely recommending it in this age range. The majority need more education about the optimal use of HPV vaccine in this age group.
-
Subjects:
-
Source:
-
Pubmed ID:33452094
-
Pubmed Central ID:PMC10206955
-
Document Type:
-
Funding:
-
Place as Subject:
-
Volume:34
-
Issue:1
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
